RNC Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $40.2M | Buy |
418,149
+6,359
| +2% | +$618K | 1.83% | 27 |
|
|
2025
Q3 | $39.2M | Sell |
411,790
-3,963
| -1% | -$364K | 1.8% | 29 |
|
|
2025
Q2 | $36.2M | Sell |
415,753
-1,268
| -0.3% | -$108K | 1.76% | 29 |
|
|
2025
Q1 | $37.5M | Buy |
417,021
+33,729
| +9% | +$3.02M | 1.91% | 27 |
|
|
2024
Q4 | $30.6M | Sell |
383,292
-52,280
| -12% | -$4.53M | 1.63% | 29 |
|
|
2024
Q3 | $34.3M | Hold |
435,572
| – | – | 1.9% | 27 |
|
|
2024
Q2 | $34.3M | Buy |
435,572
+17,642
| +4% | +$1.45M | 1.9% | 27 |
|
|
2024
Q1 | $36.4M | Buy |
417,930
+5,217
| +1% | +$445K | 2.07% | 25 |
|
|
2023
Q4 | $34M | Sell |
412,713
-30,246
| -7% | -$2.31M | 2.04% | 24 |
|
|
2023
Q3 | $34.7M | Sell |
442,959
-16,327
| -4% | -$1.37M | 2.15% | 23 |
|
|
2023
Q2 | $40.5M | Buy |
459,286
+10,508
| +2% | +$905K | 2.24% | 22 |
|
|
2023
Q1 | $36.2M | Buy |
448,778
+119,758
| +36% | +$9.76M | 2.04% | 23 |
|
|
2022
Q4 | $25.6M | Sell |
329,020
-134,324
| -29% | -$10.9M | 1.43% | 30 |
|
|
2022
Q3 | $37.4M | Sell |
463,344
-6,131
| -1% | -$551K | 2.35% | 19 |
|
|
2022
Q2 | $42.1M | Buy |
469,475
+165,060
| +54% | +$16.7M | 2.4% | 15 |
|
|
2022
Q1 | $33.8M | Buy |
304,415
+273,061
| +871% | +$28.8M | 1.71% | 27 |
|
|
2021
Q4 | $3.24M | Sell |
31,354
-8,630
| -22% | -$999K | 0.16% | 79 |
|
|
2021
Q3 | $5.01M | Buy |
39,984
+10,133
| +34% | +$1.31M | 0.27% | 63 |
|
|
2021
Q2 | $3.71M | Buy |
29,851
+9,085
| +44% | +$1.14M | 0.2% | 74 |
|
|
2021
Q1 | $2.45M | Buy |
20,766
+1,569
| +8% | +$184K | 0.14% | 82 |
|
|
2020
Q4 | $2.25M | Buy |
+19,197
| New | +$2.11M | 0.14% | 81 |
|
|
2018
Q4 | – | Sell |
-2,351
| Closed | -$231K | – | 140 |
|
|
2018
Q3 | $231K | Buy |
+2,351
| New | +$217K | 0.02% | 128 |
|
|
2017
Q4 | – | Sell |
-2,629
| Closed | -$204K | – | 153 |
|
|
2017
Q3 | $204K | Hold |
2,629
| – | – | 0.02% | 138 |
|
|
2017
Q2 | $233K | Sell |
2,629
-47
| -2% | -$3.96K | 0.02% | 131 |
|
|
2017
Q1 | $216K | Sell |
2,676
-1,482
| -36% | -$116K | 0.02% | 135 |
|
|
2016
Q4 | $296K | Buy |
4,158
+1,229
| +42% | +$96.6K | 0.02% | 119 |
|
|
2016
Q3 | $253K | Hold |
2,929
| – | – | 0.02% | 117 |
|
|
2016
Q2 | $254K | Hold |
2,929
| – | – | 0.02% | 117 |
|
|
2016
Q1 | $220K | Sell |
2,929
-369
| -11% | -$27.8K | 0.02% | 123 |
|
|
2015
Q4 | $254K | Sell |
3,298
-24
| -0.7% | -$1.81K | 0.03% | 124 |
|
|
2015
Q3 | $222K | Hold |
3,322
| – | – | 0.02% | 116 |
|
|
2015
Q2 | $246K | Hold |
3,322
| – | – | 0.02% | 116 |
|
|
2015
Q1 | $259K | Buy |
+3,322
| New | +$252K | 0.02% | 114 |
|
Other funds holding MDT
RNC Capital Management's MDT Position: Q4 2025 in Review
RNC Capital Management increased its Medtronic (MDT) stake by 1.5% in Q4 2025, buying an estimated $618K and bringing the position to 418,149 shares worth $40.2M. The position accounts for 1.83% of the portfolio, ranked #27.
RNC Capital Management first reported a position in MDT in Q1 2015 and has held it in 33 quarters since. The position peaked at $42.1M in Q2 2022. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.
- RNC Capital Management held 418,149 shares of Medtronic worth $40.2M as of Q4 2025.
- RNC Capital Management bought 6,359 Medtronic shares in Q4 2025, an estimated $618K.
- Medtronic made up 1.83% of RNC Capital Management's portfolio in Q4 2025, its #27 holding.
- RNC Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 33 quarters since.
- RNC Capital Management's Medtronic position peaked at $42.1M in Q2 2022.
- 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.